• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: January 2019

Finance

Eagle Genomics Closes $3.5M Investment

January 31, 2019 Microbiome Times

Microbiome discovery platform company Eagle Genomics announces funding of $3.5M led by the Environmental Technologies Fund (ETF Partners), a European growth fund specialising in promoting sustainability through innovation. The raise will accelerate the development of […]

Pharma & Human Health

4D Pharma Announces Publication of Data Highlighting Immuno-Stimulatory Properties of MRx0518

January 29, 2019 Microbiome Times

4D pharma plc (AIM: DDDD) announces the publication of a paper outlining the mechanism and strong immuno-stimulatory effects of MRx0518. The paper ‘The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant‘ […]

Pharma & Human Health

Evelo Announces Dosing of First Patient in Phase 2a Clinical Trial in Patients with Metastatic Melanoma

January 29, 2019 Microbiome Times

Evelo Biosciences, Inc.(Nasdaq: EVLO) (“Evelo”), a biotechnology company developing monoclonal microbials, a new modality of oral biologic medicines, announced that the University of Chicago has dosed the first patient in an investigator-sponsored Phase 2a clinical […]

Pharma & Human Health

Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For NASH

January 24, 2019 Microbiome Times

Second Genome, Inc., a clinical-stage company focused on the development of novel therapeutics identified through microbiome science, today announced that the first patient has been dosed in a Phase 2 clinical trial evaluating SGM-1019 for […]

Animal Health

Chr. Hansen Ranked as the Most Sustainable Company in the World

January 22, 2019 Microbiome Times

One month short of its official 145th anniversary, global bioscience company Chr. Hansen is ranked the most sustainable company in the world by Corporate Knights, a specialized Toronto-based media and investment research firm. This was […]

Finance

Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments

January 22, 2019 Microbiome Times

Ferring Pharmaceuticals and Karolinska Institutet announced today a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and women’s health and gastroenterology. The collaboration brings together specialist expertise […]

Finance

Bioharmony Therapeutics and Boehringer Ingelheim to Advance Bacteriophage Lysin Therapeutics

January 16, 2019 Microbiome Times

Bioharmony Therapeutics, Inc. (“Bioharmony”), a biopharmaceutical company focusing on the development of novel therapeutics for hard to treat bacterial infections, announced today that it has entered into a Collaborative Research and Licensing Agreement with Boehringer […]

Finance

Seres Therapeutics Announces Chief Executive Officer Transition

January 16, 2019 Microbiome Times

Seres Therapeutics, Inc. (Nasdaq: MCRB) announced the appointment of Eric D. Shaff as President and Chief Executive Officer. Mr. Shaff, who is currently Chief Operating and Financial Officer, succeeds Roger J. Pomerantz, M.D. Mr. Shaff […]

Pharma & Human Health

New ELISA Blood Test Offers Important Insights to Patients with Scleroderma and Systemic Sclerosis

January 15, 2019 Microbiome Times

The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with scleroderma and associated with gastrointestinal complications. This suggests a link between scleroderma and the gut microbiome, a finding […]

Pharma & Human Health

Large Meta-Analysis Backs Probiotic Benefits in Gut Health

January 13, 2019 Microbiome Times

A systematic review and meta-analysis was recently published in the World Journal of Clinical Cases1 that asses the effects of probiotic preparation Medilac-S® (Enterococcus faecium Rosell®-26 and Bacillus subtilisRosell®-179), as adjunctive therapy in ulcerative colitis […]

Finance

OraSure Technologies, Inc. Announces Acquisition of CoreBiome

January 10, 2019 Microbiome Times

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, announced that it has entered into definitive agreements to acquire CoreBiome. The transactions are expected to close […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
  • Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
    March 5, 2025
  • Scientists decode diet from stool DNA – no questions asked
    February 24, 2025
sign up

Sign up to the Microbiome Times newsletter